PATENT CLAIM ANALYSIS

Application Number: 15744054
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "019300"]

Abstract:
The present invention refers to new binding proteins based on di-ubiquitin modified in 12, 13, or 14 positions selected from positions R42, I44, H68, V70, R72, L73, R74, K82, L84, Q138, K139, E140, S141, and T142 of di-ubiquitin and being able to bind specifically with high affinity to selected targets. Furthermore, the invention provides a method for the generation of said binding proteins. In addition, libraries encoding for said binding proteins based on di-ubiquitin muteins modified in 12, 13, or 14 positions selected from R42, I44, H68, V70, R72, L73, R74, K82, L84, Q138, K139, E140, S141, and T142 are provided.

Claim (Index 24):
The method of  claim 15 , wherein the disease or disorder is cancer or an autoimmune disorder.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 86.0
- Lexical Diversity: 2.22951
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14126358', '13144809', '14442376', '12293715', '13514133']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7424558742832815
- 35 USC 102 Novelty (BERT): 0.5320101096130813
- Combined Prediction Score: 0.7214112978162616
- Mean Citation Score: 294.255452
- Max Citation Score: 307.40186
- Similarity Product: 181.53058170752524

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test